
Baraclude 1mg Tablet
Marketer
BMS India Pvt Ltd
Salt Composition
Entecavir (1mg)
Overview Baraclude 1mg Tablet
Hepatitis B virus (HBV) infection is treated with the antiviral medication entecavir. Its mechanism involves hindering viral replication, consequently lowering the HBV load within the body. This suppression of viral activity slows liver damage progression. Baraclude 1mg tablets should be ingested on an empty stomach, adhering precisely to your physician's prescribed dosage and duration. Strict adherence to the prescribed regimen significantly enhances treatment efficacy, improving liver function and mitigating the risk of complications linked to chronic HBV. While Baraclude may not definitively prevent liver cancer or cirrhosis, it helps manage the HBV infection. Consistent medication use, as directed by your doctor, is crucial. Common, usually mild, side effects include headache, nausea, vomiting, abdominal pain, tiredness, and diarrhea; however, persistent or bothersome symptoms warrant medical attention. Rarely, skin reactions or liver injury may occur, necessitating close medical monitoring, particularly during initial treatment. Prior to commencing treatment, disclose any pre-existing skin conditions or kidney issues. Regular blood tests to evaluate blood cell counts and liver health are typically required. Alcohol consumption should be avoided due to the increased risk of liver harm. Pregnant or breastfeeding individuals must consult their physician. If HIV-positive, avoid unprotected sex and sharing personal items; discuss safe sex practices, such as condom use, with your doctor to prevent HIV transmission.
Uses of Baraclude 1mg Tablet
Persistent infection with the hepatitis B virus (HBV)
Major Benefits of Baraclude 1mg Tablet:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Baraclude 1mg Tablet on an empty stomach.
Common Side effects of Baraclude 1mg Tablet:
- Headache
- Nausea
- Vomiting
- Fatigue
- Stomach pain
- Diarrhea
How to use Baraclude 1mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 1mg Baraclude tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Baraclude 1mg Tablet works:
Entecavir 1mg tablets offer antiviral action, inhibiting viral replication within human cells. This halts further viral production, thus resolving the infection.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of consuming alcohol while taking Baraclude 1mg Tablet is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Baraclude 1mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Baraclude 1mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a 1mg Baraclude tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with impaired kidney function should use Baraclude 1mg tablets with care, as dose modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Entecavir 1mg tablets are suitable for patients with hepatic impairment. No alteration of the entecavir 1mg tablet dosage is advised.
What if you forget to take Baraclude 1mg Tablet :
Should you forget a Baraclude 1mg Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing schedule. Never take a double dose.
Facts to Know About Baraclude 1mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Analogous nucleoside |
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
| Actions | Reverse transcriptase inhibitors (RTIs) based on nucleosides or nucleotides |
